Subscribe
4kclips / Shutterstock.com
13 June 2025NewsEuropeMarisa Woutersen

UK govt sets sights on being AI drug discovery ‘world leader’

Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
As AI shakes up pharma and biotech, can patent law keep up?
22 May 2025   Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis.
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025   Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024   Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Europe
As AI shakes up pharma and biotech, can patent law keep up?
22 May 2025   Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis.
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025   Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024   Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.

More on this story

Europe
As AI shakes up pharma and biotech, can patent law keep up?
22 May 2025   Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis.
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025   Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024   Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.

More features

UPC promises CMS overhaul with new phased release
Vidal: Coke Morgan Stewart's rulings are 'taxing innovation'
Sheppard Mullin expands practice with Perkins Coie trio
Synthego clears rival’s patents from CRISPR market at Fed Circ
Three reasons why the UK should reconsider joining the UPC
Fed Circ affirms rulings in Acadia’s fight against Parkinson’s drug copies
USPTO’s Stewart: Don’t nix patents as penalty for misconduct
Fed Circ upholds Moderna’s COVID-19 vaccine win against Alnylam